You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

newly diagnosed AML

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Neutropenia Trial in Houston (Isavuconazole)

Completed
Has Results
  • Acute Myeloid Leukemia
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2021

Acute Myeloid Leukemia, Blasts 20 Percent or More of Bone Marrow Nucleated Cells, High Risk Myelodysplastic Syndrome Trial in

Recruiting
  • Acute Myeloid Leukemia
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 7, 2022

Acute Myeloid Leukemia, Adult, AML, AML, Adult Trial in La Jolla (Fludarabine, Vyxeos)

Recruiting
  • Acute Myeloid Leukemia, Adult
  • +2 more
  • La Jolla, California
    UCSD Moores Cancer Center
Mar 30, 2021

Leukemia, Myeloid, Acute Trial (The combination of HHT, venetoclax, AZA, G-CSF)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • The combination of HHT, venetoclax, AZA, G-CSF
  • (no location specified)
Mar 28, 2021

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

Completed
Has Results
  • Acute Myeloid Leukemia
  • +2 more
  • Laboratory Biomarker Analysis
  • Liposome-encapsulated Daunorubicin-Cytarabine
  • Houston, Texas
    M D Anderson Cancer Center
Jan 8, 2021

Acute Myeloid Leukemia (AML) Trial in China (Venetoclax, Azacitidine)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Beijing, Beijing, China
  • +23 more
Aug 12, 2022

Acute Myeloid Leukemia Trial in Beijing (azacytidine;cytarabine;aclamycin;Chidamide;venetoclax;granulocyte)

Recruiting
  • Acute Myeloid Leukemia
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Dec 13, 2022

Leukemia, Monocytic, Acute, Pediatric AML Trial in China (Cladribine, G-CSF, Cytarabine)

Recruiting
  • Leukemia, Monocytic, Acute
  • Pediatric AML
  • Foshan, Guangdong, China
  • +8 more
Mar 28, 2022

Acute Myeloid Leukemia Trial in Beijing (Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte

Recruiting
  • Acute Myeloid Leukemia
  • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
  • "3+7"
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Sep 29, 2023

Acute Monocytic Leukemia, Newly Diagnosed Trial in Suzhou (Chidamide, Azacitidine, Venetoclax)

Recruiting
  • Acute Monocytic Leukemia
  • Newly Diagnosed
  • Suzhou, Jiangsu, China
    The First Affliated Hospital of Soochow University
Oct 3, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Philadelphia (STAT

Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • STAT Inhibitor OPB-111077
  • +3 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Dec 20, 2022

Acute Myeloid Leukemia Trial in Singapore, United States (Cytarabine, Daunorubicin, Etoposide)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Palo Alto, California
  • +7 more
Aug 6, 2021

Acute Myeloid Leukemia Trial in France (Dexamethasone)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Angers, France
  • +24 more
Jul 26, 2022

Leukemia, Myeloid, Acute Trial in Guanzhou (Azacitidine, Venetoclax)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • Guanzhou, Guandong, China
    Nanfang Hospital of Southern Medical University
Jul 22, 2022

Prostate Cancer, Newly-Diagnosed Prostate Cancer Trial ([18F]PSMA-1007)

Not yet recruiting
  • Prostate Cancer
  • Newly-Diagnosed Prostate Cancer
  • (no location specified)
Nov 3, 2023

Acute Myeloid Leukemia, Elderly Patients, Newly Diagnosed Trial in Guangzhou (Cladribine Injection, Aclarubicin, G-CSF)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Cladribine Injection
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Dec 15, 2020

Acute Myeloid Leukemia Trial in United States (Quizartinib, Milademetan)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +7 more
Mar 14, 2022

Leukemia, Myeloid, Acute, De Novo, Age More 60yr Trial in Spain (Azacitidine, Venetoclax, Quizartinib)

Recruiting
  • Leukemia, Myeloid, Acute
  • +2 more
  • Alcalá De Henares, Spain
  • +14 more
May 17, 2021

AML, FLT3-ITD Mutation Trial in Hong Kong (Quizartinib, Omacetaxine Mepesuccinate Injection)

Unknown status
  • AML
  • FLT3-ITD Mutation
  • Hong Kong, Hong Kong
    The University of Hong Kong
Dec 9, 2020

Acute Myeloid Leukemia Trial in Munich (Azacitidine Injection, Nivolumab, Relatlimab)

Recruiting
  • Acute Myeloid Leukemia
  • Azacitidine Injection
  • +2 more
  • Munich, Germany
    University Hospital, LMU Munich
May 30, 2021

Acute Myeloid Leukemia (AML) Trial in Austria, Germany (Dasatinib, Cytarabine, Daunorubicin)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • Innsbruck, Austria
  • +53 more
Sep 19, 2022

Acute Myeloid Leukemia Trial (Azacitidine, Biospecimen Collection, Bone Marrow Aspirate)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Nov 4, 2022

Newly Diagnosed Peripheral T-cell Lymphoma Trial in Wuhan (Duvelisib, Chidamide)

Recruiting
  • Newly Diagnosed Peripheral T-cell Lymphoma
  • Duvelisib, Chidamide
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Jul 27, 2023

nk/T-cell Lymphoma, Newly Diagnosed, Advanced Lymphoma Trial in Beijing (XPO1 inhibitor)

Recruiting
  • nk/T-cell Lymphoma
  • +2 more
  • XPO1 inhibitor
  • Beijing, Haidian, China
    ChinaPLAGH
Apr 18, 2023

Type 1 Diabetes, Type 1 Diabetes (Juvenile Onset), Diabetes, Type 1 Trial in Indianapolis (HAMS-AB, Placebo)

Not yet recruiting
  • Type 1 Diabetes
  • +2 more
  • Indianapolis, Indiana
    Indiana School of Medicine
Sep 28, 2023